The Role of the Gastrointestinal Microbiota in Parkinson’s Disease
Biomolecules · 28.12.2024 · 15 (1) · 26
DOI: 10.3390/biom15010026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 28.12.2024. Verfasst von Maurizio Gabrielli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome,…. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons leading to debilitating motor and non-motor symptoms. Beyond its well-known neurological features, emerging evidence underscores the pivotal role of the gut–brain axis and gastrointestinal microbiota in PD pathogenesis. Dysbiosis has been strongly linked to PD and is associated with increased intestinal permeability, chronic inflammation, and the production of neurotoxic metabolites that may exacerbate neuronal damage.
Methods
This review delves into the complex interplay between PD and dysbiosis, shedding light on two peculiar subsets of dysbiosis, Helicobacter pylori infection and small-intestinal bacterial overgrowth. These conditions may not only contribute to PD progression but also influence therapeutic responses such as L-dopa efficacy.
Conclusions
The potential to modulate gut microbiota through probiotics, prebiotics, and synbiotics; fecal microbiota transplantation; and antibiotics represents a promising frontier for innovative PD treatments. Despite this potential, the current evidence is limited by small sample sizes and methodological variability across studies. Rigorous, large-scale, randomized placebo-controlled trials with standardized treatments in terms of composition, dosage, and duration are urgently needed to validate these findings and pave the way for microbiota-based therapeutic strategies in PD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Internal Medicine Department, San Carlo di Nancy Hospital, Università UniCamillus, 00131 Rome, Italy.
ORCID-Profile: Maurizio Gabrielli, Veronica Ojetti, Antonio Gasbarrini
Zitieren
APA
Gabrielli, M., Zileri Dal Verme, L., Zocco, M. A., Nista, E. C., Ojetti, V., & Gasbarrini, A. (2024). The Role of the Gastrointestinal Microbiota in Parkinson’s Disease. Biomolecules, 15(1), 26. https://doi.org/10.3390/biom15010026
Vancouver
Gabrielli M, Zileri Dal Verme L, Zocco MA, Nista EC, Ojetti V, Gasbarrini A. The Role of the Gastrointestinal Microbiota in Parkinson’s Disease. Biomolecules. 2024;15(1):26. doi:10.3390/biom15010026
BibTeX
@article{Gabrielli2024,
author = {Gabrielli, Maurizio and Zileri Dal Verme, Lorenzo and Zocco, Maria Assunta and Nista, Enrico Celestino and Ojetti, Veronica and Gasbarrini, Antonio},
title = {The Role of the Gastrointestinal Microbiota in Parkinson’s Disease},
journal = {Biomolecules},
year = {2024},
volume = {15},
number = {1},
pages = {26},
doi = {10.3390/biom15010026}
}
EUVIMED